|
| Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget’s disease |
|
https://doi.org/10.18632/oncotarget.27272
Thierry M. Nordmann, Olivia Messerli-Odermatt, Larissa Meier, Sara Micaletto, Thomas Coppetti, Mirjam Nägeli, Jivko Kamarachev, Ken Kudura, Sandra N. Freiberger, Tamara Rordorf, Joanna Mangana, Ralph Braun, Reinhard Dummer
|
| 6647-6650 |
|
| A squalamine derivative, NV669, as a novel PTP1B inhibitor: in vitro and in vivo effects on pancreatic and hepatic tumor growth |
|
https://doi.org/10.18632/oncotarget.27286
Sylvie Carmona, Jean-Michel Brunel, Rénaté Bonier, Véronique Sbarra, Stéphane Robert, Patrick Borentain, Dominique Lombardo, Eric Mas, René Gerolami
|
| 6651-6667 |
|
| Caveolin-1 Y14 phosphorylation suppresses tumor growth while promoting invasion |
|
https://doi.org/10.18632/oncotarget.27313
Bharat Joshi, Judy Pawling, Jay Shankar, Karina Pacholczyk, Yohan Kim, Wynn Tran, Fanrui Meng, Anas M. Abdel Rahman, Leonard J. Foster, Hon S. Leong, James W. Dennis, Ivan R. Nabi
|
| 6668-6677 |
|
| Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade |
|
https://doi.org/10.18632/oncotarget.27320
Sheila Dakhel, Tiziano Ongaro, Baptiste Gouyou, Mattia Matasci, Alessandra Villa, Dario Neri, Samuele Cazzamalli
|
| 6678-6690 |
|
| Avoidance of apoptotic death via a hyperploid salvage survival pathway after platinum treatment in high grade serous carcinoma cell line models |
|
https://doi.org/10.18632/oncotarget.27330
Tony Yeung, Oliver Fung, Mikhail Bashkurov, Arian Khandani, Omar Subedar, Alexandra Wudwud, Patricia Shaw, Blaise Clarke, John Bartlett, Robert Rottapel, Andras Kapus
|
| 6691-6712 |
|
| Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: A proteomics-based study |
|
https://doi.org/10.18632/oncotarget.27333
Andro Košec, Ruđer Novak, Paško Konjevoda, Vladimir Trkulja, Vladimir Bedeković, Lovorka Grgurević
|
| 6713-6722 |
|
| Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent |
|
https://doi.org/10.18632/oncotarget.27336
Anne-Julie Cloux, Dominique Aubry, Mathieu Heulot, Christian Widmann, Oussama ElMokh, Francesco Piacente, Michele Cea, Alessio Nencioni, Axel Bellotti, Karima Bouzourène, Maxime Pellegrin, Lucia Mazzolai, Michel A. Duchosal, Aimable Nahimana
|
| 6723-6738 |
|
| The impact of systemic precision medicine and immunotherapy treatments on brain metastases |
|
https://doi.org/10.18632/oncotarget.27328
Rowland H. Han, Gavin P. Dunn, Milan G. Chheda, Albert H. Kim
|
| 6739-6753 |
|
| Retraction: Relationship between rs1801157 polymorphism in stromal cell-derived factor gene and systemic lupus erythematosus risk |
|
https://doi.org/10.18632/oncotarget.27351
Can Qian, Qinghua Zou, Yong Wang
|
| 6754-6754 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
